A validated algorithm for assessing solid renal masses could be useful in clinical practice.
Patients choosing active surveillance perceived cancer and metastasis risks to be lower compared with those opting for surgery and ablation, a study showed.
Recent findings may be useful for patient counseling and in designing active surveillance research studies.
Study showed that 82% of patients had elevated CA-125 levels at any point during their disease course.
A study of patients treated for RCC found that radical nephrectomy, male sex, diabetes, hypertension, and chronic kidney disease are risk factors for end-stage kidney disease, according to investigators.
In a study of patients who had ever been diagnosed with kidney cancer, those who reported exercise or physical activity in the past 30 days had reduced likelihood of reporting worse physical and mental health.
The TARDIS assay could be used in studies to identify appropriate candidates for discontinuation of immune checkpoint inhibitors.
Investigators in Austria studied overall survival in 914 patients diagnosed with mRCC from July 1985 to September 2020.
Study provides preliminary data on triple therapy for advanced RCC while clinicians await definitive answers from the ongoing phase 3 COSMIC-313 trial.
Investigators examined outcomes of robotic radiosurgery in patients with lung, visceral, and lymph node metastases from renal cell carcinoma.
Strategies, such as booster doses, appear warranted in this population.
Use of immune checkpoint inhibitors for any line of treatment was beneficial, investigators reported.
Patients with poor performance status have been excluded from pivotal trials on metastatic renal cell carcinoma.
Investigators describe the type and frequency of adverse reactions and how clinicians managed them.